Trending News Today: US Cancer Death Rates Have Dropped Over Past 25 Years

The US cancer death rate has been dropping for at least 25 years, hitting a new milestone, the Associated Press reported. According to the article, the Cancer Society report found cancer death rates dropping 27% between 1991 and 2016, with the lung cancer death rate down by approximately 50% among men since 1991. However, the report also stated that obesity-related cancer deaths are on the rise and prostate cancer deaths are no longer decreasing, the article noted.
 
New York City Mayor Bill de Blasio announced that the city will expand health coverage to an estimated 600,000 residents currently without insurance, The Washington Post reported. According to the article, New York City will spend up to $100 million per year for the plan, which involves expanding the city’s existing public insurance programs and providing uninsured residents with access to affordable care at city-owned facilities. The plan will also aim to provide the uninsured with a range of services, including primary care physicians, mental health services, and prescription drugs, the article reported.
 
A new analysis found that prescription drug ads appeared 5 million times in 2016, with medical marketing reaching $30 billion in that year, the Associated Press reported. According to the article, marketing to physicians and other health professionals accounted for a bulk of the share but spending on consumer-focused ads also increased. The study authors indicated that the upward trend in medical marketing is concerning and suggested consumers need to be increasingly skeptical about marketing claims, the article reported.



Stay up to date on the latest news in specialty pharmacy by getting Specialty Pharmacy Times in your mailbox or inbox for free!

Click here to sign up for free for the bi-monthly Specialty Pharmacy Times print journal delivered to your address.

Click here to sign up for our email newsletters delivered every Monday, Wednesday, and Friday, in addition to breaking news alerts.

Click here to follow us on Facebook. 

Click here to follow us on Twitter. 

Click here to join our LinkedIn group. 


Most Popular

Related Articles

Although there have been links between esophageal cancer and drinking hot tea, this was the first study to examine a specific temperature.
A phase 3 study compared overall survival and cardiac safety between biosimilar trastuzumab (Ontruzant) and the reference medicine.
Top news of the day from across the health care industry.
Company Profile >
Industry Guide >
Market News >
Peer Exchange >
Conferences >
Subscribe >
Specialty Times Resources
About Us
Advertise
Careers
Contact Us
Terms & Conditions
Privacy
MJH Associates >
Pharmacy Times
OTCGuide
American Journal of Managed Care
Cure
MD Magazine
ONCLive
Targeted Oncology
Physicians' Education Resource
Pharmacy & Healthcare Communications, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright Specialty Pharmacy Times 2006-2018
Pharmacy & Healthcare Communications, LLC. All Rights Reserved.
 

$vacMongoViewPlus$